Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.68 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.67 |
| ▸ | ACE | P12821 | 4/20 | 0.67 |
| ▸ | ITGB2 | P05107 | 6/20 | 0.66 |
| ▸ | ICAM1 | P05362 | 6/20 | 0.66 |
| ▸ | ITGAL | P20701 | 6/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30051539 | 1.00 | ALOX15 (0.68) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL1407979 | 1.00 | ALOX15 (0.68) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Water SCHEMBL28029902 | 0.99 | ERAP2 (0.67) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Water SCHEMBL28029903 | 0.99 | ERAP2 (0.67) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Urea SCHEMBL2597753 | 0.97 | ERAP2 (0.65) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Urea SCHEMBL2597752 | 0.97 | ERAP2 (0.65) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL30051742 | 0.95 | ACE (0.68) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL15757296 | 0.92 | ERAP2 (0.62) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL29352080 | 0.92 | ERAP2 (0.62) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL15757291 | 0.92 | ERAP2 (0.62) | ALOX15ERAP2P2RY14ACEITGB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382911-B2 | Plant extract containing diketopiperazine and method for producing same | SUNTORY HOLDINGS LIMITED (JP) | 2022-07-12 | — | — | US | claimed |
| CN-105307514-B | Plant extracts and its manufacturing method containing diketopiperazine | 三得利控股株式会社 | 2018-11-27 | — | — | CN | claimed |
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106455664-A | Composition with high content of cyclic dipeptide | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-105307514-A | Plant extract containing diketopiperazine and method for producing same | SUNTORY HOLDINGS LTD | 2016-02-03 | — | — | CN | claimed |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-10-15 | — | — | US | claimed |
| EP-2925771-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | Council of Scientific & Industrial Research (IN) | 2015-10-07 | — | — | EP | claimed |
| WO-2014083578-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESERACH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2014-06-05 | — | — | WO | claimed |
| EP-0765152-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1997-04-02 | — | — | EP | claimed |
| US-5538945-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 1996-07-23 | — | — | US | claimed |
| WO-1995035085-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1995-12-28 | — | — | WO | claimed |
| US-4849408-A | GLYCYLTRYPTOPHAN, ANTIDEPRESSANTS, SEDATIVES | (501) FRESENIUS AG (DE) | 1989-07-18 | — | — | US | claimed |
| WO-2026089754-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026089752-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-0765152-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5538945-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
| WO-1995035085-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1995-12-28 | — | — | WO | disclosed |
| US-4849408-A | GLYCYLTRYPTOPHAN, ANTIDEPRESSANTS, SEDATIVES | (501) FRESENIUS AG (DE) | 1989-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | MUC1, VIP, LGALS4 | ALOX15 1831/4885ERAP2 3645/4885P2RY14 3222/4885 |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | CNR2, SRM, CNR1 | ALOX15 2141/4885ERAP2 3507/4885P2RY14 452/4885 |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FGF23, FIBP, PTMS | ALOX15 2551/4885ERAP2 1850/4885P2RY14 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.